{"name":"IconOVir Bio","slug":"iconovir-bio","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"globenewswire.com","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements - globenewswire.com","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE1sN0RXMkZlSi1mYjdxODJtcUZXdXZvSUt2X0I4WkI4UkVfSG1wUzlIUXJXOVNpRXJBM014NnZ4ZXJ1TVJVQUJDbUgweGh5cWlSeWI3eXB1S2xVaThJTDFKQ0hSYVd1RjNXUEtVVXNiZ1RPX05oU3N3UlBB?oc=5","date":"2025-08-01","type":"pipeline","source":"Labiotech.eu","summary":"Oncolytic virus therapy for cancer: what’s been going on in 2025? - Labiotech.eu","headline":"Oncolytic virus therapy for cancer: what’s been going on in 2025?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQOXFJaGJsVjBjaDRaczRBamphb1BOZ2t2MnZPSWN3c28wOW01SkdHYUNWQ29qWW1NeGhwNmVYdU9IemJNV1Z4RUppTWZwSVRrU3MtTkZSNUhrdzFqQk9zRmhxSWljdTNEQ1NRbzkxVkRjZjJuLWdIZG51amJ1RjZhMklVb3g5MnBHRDF6VFh5bGlQNFFZWmVsSGZ5WlhBb09aYWpRNkdaZ09pZ0pqTmRCNWc4ZHVocVVjanJoc1dsVjkteXFKYTFfZQ?oc=5","date":"2025-05-12","type":"earnings","source":"BioSpace","summary":"UroGen Pharma Reports First Quarter 2025 Financial Results and Provides a Business Update - BioSpace","headline":"UroGen Pharma Reports First Quarter 2025 Financial Results and Provides a Business Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOaXVMTVFobktFaUNaU2daTHNYVVlNRGwtLWdZUjdJb0h5a0FERVBpYXprNXpVREFOSDJpRTRuRnZtRDRtUFJrcjJ1UzZyVGpHUDJiXzA0Qm1hUktnWVd6d1JDdm8yX093aGVudzU3ZHZ5T3ZudDFsbE1DZnZ6d0dtbHNzd2JlUQ?oc=5","date":"2025-02-21","type":"deal","source":"Pharmaceutical Technology","summary":"UroGen acquires IconOVir’s oncolytic virus assets - Pharmaceutical Technology","headline":"UroGen acquires IconOVir’s oncolytic virus assets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPYlhLRWQzSjhnR0ZrdWZqaWJLd094eFRqTy1BSTI1SXVrUW9pZVRZQzNuc3hYUjVpUU1JYkFUZm5SQUwtNTN3VDh1d0t2c25Mb3JjVVo4SDNSTEdySzlFcXNfZjRMa3NCU0hSZXlfLW1iV0tCQm50X2FyWklveVAxY0FrUWc0MGptZDZhSEtZUDFSWW5KNVJMZFlmYXlhVGxrcFotd0Z1VmJJUQ?oc=5","date":"2025-02-20","type":"pipeline","source":"Fierce Biotech","summary":"IconOVir, 4 years on from flashy launch, sells oncolytic virus to UroGen for $4M in stock - Fierce Biotech","headline":"IconOVir, 4 years on from flashy launch, sells oncolytic virus to UroGen for $4M in stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxOUVFrV1pReGFjQ2Y4TEEzNkhFb0cyUGRmYjFTbEtieHlEQlVNUlU0RElEWmV0RkJLbW1UbWEyb1VWb05YZzh5X1EtalVGb3l1QW02X29WV3VPQkNsZGdoVmk2Tm1XTlJrLVZwdzY2QVVGaUJJZExBNHdSQlhtZ3J3clg0S3h5Z0lTcUYzXzBXc1EtR2IzVkdIcUZ0UjkySTlYTU1iVFZuSWpfN0c5bjd4UEFUakphRWljNlBfZDhXS21KMldpanF1STdWUXNpYlh4TUlpWmJkREdnOE16RzhockI5Z0x6S1ZqSm1XVFJCMU5rTWZ2bE1Ud18waHZEbXJNV3F0d1piVlcwU3BYLU02WTVWYnlaM2dDY1licVgzV0lHbHBsRGcyQW95MWdPNUxocTJodXF3?oc=5","date":"2025-02-20","type":"deal","source":"BioSpace","summary":"UroGen Advances Long-Term Growth Strategy by Acquiring a Next-Generation Investigational Oncolytic Virus (ICVB-1042) and Announces Multiple Strategic Research Collaborations - BioSpace","headline":"UroGen Advances Long-Term Growth Strategy by Acquiring a Next-Generation Investigational Oncolytic Virus (ICVB-1042) and","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQQTVkNE1adzJfakdHaWNHN25obHp0UFFUTzcwYjR6WURFX2xVUkI1Q3c3Q1ZKNUhIby1mUGhlWWl2TTJDRmNuSGpaUktkS0NSbXlpb0g5NUczaFd1T3hBU3pqaHptUGVOdC12NWt4RjM1U2VLYll4OGR2MjFkemFzOTk0RkNsTF9iTVR3dDlnenhJSUpMR2xqNjNwN24?oc=5","date":"2024-01-12","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Former Celgene CEO Alles takes the top job at TORL - Fierce Biotech","headline":"Chutes & Ladders—Former Celgene CEO Alles takes the top job at TORL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQSkN5UUFYWG1hd0VFbzVZU1VUb2pMQUZmdXpOc0pkSC0tLWNyOTYtTmJXcV9Xb2JDTGI4YW1SaEc1ZzdfOGs1YjZEaW9oZ2w0NjdCQzMxUDFMQ1pPM2JUMlYzelRsSWcteHhMZHNyTXJDVWRycHJ3TW1aYWVoNE9YMjBuVDZwRDNaOWNwTW9vMlFFdEMtVFp6cTVCSHREeWdFemJUNXYzWGYtd2NHVGk2dlR5VFlkT1RHaF9RblJsLVFVSjN2LVBSZUdvdw?oc=5","date":"2024-01-08","type":"pipeline","source":"PR Newswire","summary":"Ginkgo Bioworks Announces Inaugural Members of New Biopharma Advisory Board - PR Newswire","headline":"Ginkgo Bioworks Announces Inaugural Members of New Biopharma Advisory Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOQjNobFlRUzcwcVkzenYxb0lxby1yczZtOXc5TG56eWVlSXVNVzNUamRyWTNiOVp3RzJ2azQ0TXJwLWdkYVMzY3JWZjduUHBpSlJtOXpBMkF1c1hJQmZsR05IMThpNk9XOEFHelpGUnRhSjZBT3pCdHl6Y01sX1hoWUpoRlZmU0xxRC1Ddw?oc=5","date":"2021-01-05","type":"pipeline","source":"BioPharma Dive","summary":"A new, well-connected biotech aims to fight cancer with viruses - BioPharma Dive","headline":"A new, well-connected biotech aims to fight cancer with viruses","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPWm9TY0c4ejlaQ2lzWU1nalpjSXZtOXBsUzRvUzduaXc2dW1ILVNmT1FZUXdFNjYydmx3Y0haNnBhTHFKUy02aHpobjdwUWRmNWJtQ1NiRVcyeEgzb1Yyc2hhaWI5X2dydkRielR6RkVuX3JsMWpMbV9ubDhpODB1TVpiblk1aTB4SjFVRUFuSkRxdHluTVBJOTNlNFBVTnB4NUlBekdadnFNOFZqbmh3SUY2VzZCUkdQLS1MdUZNRmhyQQ?oc=5","date":"2021-01-05","type":"pipeline","source":"Fierce Biotech","summary":"IconOVir uncloaks with $77M, ex-Forty Seven CEO and cancer-killing viruses out of Salk Institute - Fierce Biotech","headline":"IconOVir uncloaks with $77M, ex-Forty Seven CEO and cancer-killing viruses out of Salk Institute","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}